Clinical Trial Update: Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating the combination of trastuzumab with chemotherapy in women with stage I-III HER2-positive breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Modena | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN